By Matt Jones

NEW YORK (GenomeWeb News) – The annual ritual that National Institutes of Health directors make of heading to Capitol Hill to justify their fiscal budgets and to make the case for supporting biomedical research could become easier — if a new initiative to monitor federal investments in science achieves its goals.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The new Riken president outlines some of his plans for the institute.

The Guardian discusses whether big science projects are worth the loss of resources available for other scientific pursuits.

An NEJM update from the ClinVar team highlights the difficulties of interpreting genetic variants.

In Nature this week: genomic analysis of high-grade serous ovarian cancer, and more.